Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter

Molecules and Cells

Volumn 9, Issue 5, 1999, Pages 560-563

  Song, Hyejin ^a   Kim, Jae Hyun ^a   Rho, Jae Kyun ^a   Park, Sun Young ^a   Kim, Chul Geun ^b   Choe, Soo Young ^a  

^a Chungbuk National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

AML1; Human CR1; TEL; TEL AML1; Transcription

Indexed keywords

COMPLEMENT RECEPTOR; DNA BINDING PROTEIN; HYBRID PROTEIN; ONCOPROTEIN; TEL AML1 FUSION PROTEIN; TEL-AML1 FUSION PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1; TUMOR PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; BINDING SITE; BIOSYNTHESIS; CELL CULTURE; CELL TRANSFORMATION; CHROMOSOME 12; CHROMOSOME 21; ERYTHROLEUKEMIA; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETIC TRANSFECTION; GENETICS; HEMATOPOIESIS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; ULTRASTRUCTURE;

BINDING SITES; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIESIS; HUMANS; LEUKEMIA, B-CELL; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROMOTER REGIONS (GENETICS); RECEPTORS, COMPLEMENT; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033621212     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1016-8478(23)13585-0     Document Type: Article

References (15)

1. Boral, A. L., Okenquist, S. A., and Lenz, J. (1989) Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J. Virol. 63, 76-84.
2. Fears, S., Gavin, M., Zhang, D., Hetherington, C., Ben-David, Y., Rowley, J. D., and Nucifora (1997) Functional characterization of ETV6 and ETV6/EBFA2 in the regulation of the MCSFR proximal promoter. Proc. Natl. Acad. Sci. USA 94, 1949-1954.
3. Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., and Gilliland, D. G. (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 92, 4917-4921.
4. Hiebert, S., Sun, W., Davis, N., Golub, T., Shurtleff, S., Buijs, A., Downing, J., Grosveld, G., Roussel, M., Gilliland, D. G., Lenny, N., and Meyer, S. (1996) The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16, 1349-1355.
5. Hsiang, Y. H., Spencer, D., Wang, S., Speck, N. A., and Raulet, D. H. (1993) The role of C-Myb or a related factor in regulating the T-cell receptor gamma gene enhancer. J. Immunol. 150, 3905-3916.
6. Kagoshima, H., Shigesada, K., Satake, M., Ito, Y., Miyoshi, H., Ohki, M., Pepling, M., and Gergen, J. P. (1993) The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet. 9, 338-341.
7. Kim, J. H., Lee, S., and Choe, S. Y. (1999a) Characterization of the human CR1 gene promoter. Bioch. Mol. Bio. Int. 47, 655-663.
8. Kim, J. H., Lee, S., Rho, J. K., and Choe, S. Y. (1999b) AML1, the target of chromosomal rearrangment in human leukemia, regulates the expression of human complement receptor type 1 (CR1) gene. Int. J. Biochem. and Cell Biol. 31, 933-940.
9. Liu, P., Tarle, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., and Collins, F. S. (1993) Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261, 1041-1044.
10. Meyer, S., Lenny, N., Sun, W. H., and Hiebert, S. W. (1995) Functional domains of the t(8;21) fusion protein, AML-1/ ETO. Mol. Cell. Biol. 15, 1974-1982.
11. Prosser, H. M., Wotton, D., Gegonne, A., Ghysdael, J., Wang, S., Speck, N. A., and Owen, M. J. (1992) A phorbol ester response element with in the human T-cell receptor beta-chain enhancer. Proc. Natl. Acad. Sci. USA 89, 9934-9938.
12. Raynaud, S., Cave, H., Baens, M., Bastard, C., Cacheux, V., Grosgeorge, J., Guidal-Giroux, C., Guo, C., Vilmer, E., Marynen, P., and Grandchamp, B. (1996) The 12;21 translocation involving TEL and deletion of the other TEL allele; two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood. 87, 2891-2899.
13. Redondo, J. M., Pfohl, J. L., Hernandez-Munain, C., Wang, S., Speck, N.,A., and Krangel, M. S. (1992) In distinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. Mol. Cell. Biol. 12, 4817-4823.
14. Shoemaker, S. G., Hromas, R., and Kaushansky, K. (1990) Transcriptional regulation of interleukin-3 gene expression in T-lymphocytes. Proc. Natl. Acad. Sci. USA 87, 9650-9654.
15. Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., and Hiebert, S. W. (1998) The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha dependent transcription, and blocks granulocytic differentiation. Mol. Cell. Biol. 18, 322-333.